UK science and innovation under parliamentary committee spotlight:
This article was originally published in Clinica
The UK House of Commons' Committee on Science and Technology (STC) will be conducting an introductory hearing with Professor Sir Keith O'Nions, director general of the Research Councils, on May 12 2004. The oral evidence session will focus on the government's 10-year investment framework for science and innovation and the progress of the current review of Research Councils UK. It will consider his views on the work of the Research Councils and his role since his appointment on January 1.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.